Provention Bio (PRVB) Announces Trading Halted Today for FDA Advisory Committee Meeting on Teplizumab

Go back to Provention Bio (PRVB) Announces Trading Halted Today for FDA Advisory Committee Meeting on Teplizumab

Provention Bio Stock Trading Halted Today

May 27, 2021 7:05 AM EDT

RED BANK, N.J., May 27, 2021 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today announced that Nasdaq has halted trading of the Company's common stock.

The... More